Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society-Reference-Cited by-同舟云学术

Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society

Published:2022-05 Issue:5 Volume:3 Page:100317
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Ozawa Yuichi^ORCID,Yamamoto Nobuyuki,Yamamoto Kouji,Ito Kentaro,Kenmotsu Hirotsugu,Hayashi Hidetoshi,Shukuya Takehito,Fujimoto Daichi,Sugawara Shunichi,Niho Seiji,Ohe Yuichiro,Okamoto Hiroaki,Nakagawa Kazuhiko,Kiura Katsuyuki,Yoshino Ichiro,Gemma Akihiko

Funder

The Japan Lung Cancer Society

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Clinical trial participants' views of the risks and benefits of data sharing;Mello;N Engl J Med,2018

2. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment;Baronikova;BMJ,2019

3. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812);Atagi;Jpn J Clin Oncol,2005

4. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301);Atagi;Lancet Oncol,2012

5. Chemoradiotherapy in elderly patients with non-small-cell lung cancer: long-term follow-up of a randomized trial (JCOG0301);Atagi;Clin Lung Cancer,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivorship program including long‐term toxicities and quality‐of‐life development over 10 years in a randomized trial in operable stage III non‐small‐cell lung cancer (ESPATUE);International Journal of Cancer;2024-08-28

2. Survivorship Program Including Long-Term Toxicities and Quality-of-Life Development Over Ten Years within a Randomized Phase-III Trial in Operable Stage III Non-Small-Cell Lung Cancer (ESPATUE);2023-12-11

3. Erratum;JTO Clinical and Research Reports;2023-02